Prior normality and homogeneity tests for dependent variables
depression, moyamoya disease, cerebral ischemia
MOYAMOYA DISEASE, CEREBRAL ISCHEMIA
The Shapiro–Wilk test to check the prior normality of the dependent variables yielded results, including stress (W = .964, p = .687; W = .917, p = .143), moyamoya disease knowledge (W = .926, p = .174; W = .968, p = .243), social support (W = .932, p = .199; W = . 961, p = .241), integration (W = .942, p = .353; W = .936, p = .273), moyamoya disease health behavior (W = .924, p = .223; W = .909, p = .107), depression (W = .936, p = .194; W = 954, p = .580), incidence of cerebral ischemia (W = .941, p = .194; W = 978, p = .693), subjective health status (W = .942, p = .354; W = .935, p = .273), quality of life (W = .954, p = .752; W = .939, p = .343), for the intervention and the control groups, respectively. Hence, normality was confirmed, and parametric analysis was used.The result of the homogeneity test for the dependent variables of the intervention and the control groups showed that there was no statistical difference between the two groups in all variables (p>.05); hence, the homogeneity between the two groups was confirmed (